Brain Cancers
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you your search results in order of date.
13777 records returned
Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSION. Our hypothesis was disproved. We found substantial
interreader disagreement and indications that the very nature of the
measurement method produces a high rate of false-positive readings of stable
tumors. These findings should be considered in interpretation of images with
this widely accepted criterion for brain tumor progression. (Source: American Journal of Roentgenology)
Source: American Journal of Roentgenology - November 20, 2009 Category: Radiology Authors: Provenzale, J. M., Ison, C., DeLong, D. Tags: Neuroradiology/Head and Neck Imaging Source Type: journals
European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma (GBM), the most aggressive type of primary malignant brain cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - November 20, 2009 Category: Pharmaceuticals Source Type: organizations
Secondary Tics or Tourettism Associated With a Brain TumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tourette syndrome is generally considered to be a genetic disorder, but symptoms mimicking Tourette syndrome can be secondary to an underlying lesion disrupting the basal ganglia circuitry. Described here is a case of secondary tics, or tourettism, in a child with a large oligodendroglioma of the right temporal lobe extending to the basal ganglia. He presented with attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and stimulant-induced tic disorder at the age of 11 years, and later also had also seizures. The family history was unremarkable. Cranial magnetic resonance imaging disclosed a right tempor...
Source: Pediatric Neurology - November 20, 2009 Category: Neurology Authors: Aimee F. Luat, Michael E. Behen, Csaba Juhász, Sandeep Sood, Harry T. Chugani Tags: Case Reports Source Type: journals
European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma (GBM), the most aggressive type of primary malignant brain cancer. (Source: Roche Media News)
Source: Roche Media News - November 20, 2009 Category: Pharmaceuticals Source Type: organizations
Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In this study, dual-label immunofluorescence analysis of the proliferation marker, Ki67, and the stem cell markers, nestin and Sox2, was performed on brains of 8 week-old wild-type (WT) and Cav-1 knockout (KO) mice. Our results demonstrate an increased number of Ki67-positive nuclei in the subventricular zone (SVZ) of Cav-1 KO brains. Importantly, our dual-label immunofluorescence analyses demonstrate increased co-localization of Ki67 with both nestin and Sox2 in the SVZ of Cav-1 KO brains. Remarkably similar results were also obtained with Cav-2 and Cav-3 KO mouse brains as well, with increased proliferation of adult neur...
Source: Cell Cycle - November 20, 2009 Category: Cytology Authors: Jasmin JF, Yang M, Iacovitti L, Lisanti MP Tags: Cell Cycle Source Type: journals
University College Hospital In London Introduces Treatments Delivering Faster Form Of RadiotherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 20, 2009 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news
University College Hospital In London Introduces Treatments Delivering Faster Form Of RadiotherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. (Source: Radiology / Nuclear Medicine News From Medical News Today)
Source: Radiology / Nuclear Medicine News From Medical News Today - November 20, 2009 Category: Radiology Tags: Radiology / Nuclear Medicine Source Type: news
Twenty-one questions about mammograms, cancer screenings and early detectionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(NaturalNews) There's a lot of talk about mammograms and cancer screenings this week. A U.S. government task force altered its recommendations, saying that women under 50 should receive no mammograms at all because the risk of harm far outweighs any promise of saving lives. This, in turn, led to a very vocal backlash from cancer industry promoters and even a few deeply misinformed celebrities like Sheryl Crow who swear by mammograms. (Sheryl Crow has a poor understanding of the effects of ionizing radiation.)Rather than providing new answers, this week's debates on mammograms have actually raised all sorts of new questions...
Source: NaturalNews.com - November 20, 2009 Category: Consumer Health Advice Source Type: news
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Generally, the blood-brain barrier (BBB) of brain metastasis was thought to be disrupted.We retrospectively performed immunohistochemical staining for glucose transporter 1 (GLUT1) and breast cancer resistance protein (BCRP) to evaluate the status of the BBB in resected brain metastases. Associations between expression of GLUT1 and/or BCRP and the immunohistochemical profiles of breast cancers, such as the statuses of hormone receptors, human epidermal growth factor receptor 2 (HER2/neu), and a basal-type marker (cytokeratin 5/6, HER1), were also analyzed.The study included 29 breast cancer patients with brain metastasis w...
Source: Cancer - November 20, 2009 Category: Cancer & Oncology Authors: Kan Yonemori, Koji Tsuta, Makiko Ono, Chikako Shimizu, Akihiro Hirakawa, Tadashi Hasegawa, Yutaka Hatanaka, Yoshitaka Narita, Soichiro Shibui, Yasuhiro Fujiwara Source Type: journals
Sontag Foundation Distinguished Scientist Awards--Brain CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Inspire us. We're looking for early career scientists with the potential to create new waves across the brain cancer field. We're looking for increased survival rates and improved recovery for patients. We're looking for a cure or at the very least, treatments to make brain cancer a manageable chronic disease.In October 2010, The Sontag Foundation will present up to three Distinguished Scientist Awards to the most outstanding early career scientists with inspiring, potential-laden brain cancer research proposals. Each Award consists of a four-year funding component totaling a maximum of $600,000.Application deadline is Ma...
Source: ScanGrants feed - November 20, 2009 Category: Research Authors: Sontag Foundation Source Type: funding
How childhood stress can lead to adult depressionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Childhood should be a happy time, not a stressful time—that’s something everyone can agree on. But for many children, childhood is very stressful. Family tragedy, natural disasters, poverty, abuse or exposure to violence (in the home, in the community, or when the country is at war) are just a few examples of what can turn childhood from a dream into a nightmare.
This is terrible for children. It’s not just a matter of robbing them of happiness; more and more research is showing that stress early in life can actually change the way a child’s brain works—for life.
A study in the journal Nature Neuroscience this mo...
Source: Thrive, Children's Hospital Boston - November 19, 2009 Category: Pediatrics Authors: Claire McCarthy, MD Tags: All posts Claire McCarthy depression PTSD stress stressed kids Source Type: organizations
David XEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At twenty-one, I was diagnosed with brain cancer. I felt some relief at knowing why I had been experiencing fits of insanity and rage, but the whole cancer deal was a bit terrifying. For the first time in my life, I was given the chance to practice what I preached: to smile through the rough times, and to laugh when the river was by all means traveling too swift and deep.
read more (Source: Stand Up 2 Cancer)
Source: Stand Up 2 Cancer - November 19, 2009 Category: Cancer & Oncology Tags: Magazine RSS Source Type: consumer
Don't lose your head over beer claimEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
Although this study demonstrated a link between higher alcohol intake and reduced CHD risk, it is has several limitations. Therefore, it cannot be assumed that high levels of alcohol consumption lower the risk of CHD. People are advised not to exceed the recommended daily limits of 2-3 units a day for women and 3-4 units a day for men.
Importantly, the study did not take into account any other adverse effects of alcohol, such as the increased risk of liver disease, obesity, pancreatic diseases, certain cancers, possible addiction, depression, accidental injury or reduced judgement in social situations.
Further l...
Source: NHS News Feed - November 19, 2009 Category: Consumer Health News Tags: Food/diet Heart/lungs Source Type: news
CIRM Awards Two $19 Million Grants for Brain Tumor ResearchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Of the 14 research teams to receive 4-year grants expected to result in clinical trials, two focus on brain tumor research. (Source: National Brain Tumor Society)
Source: National Brain Tumor Society - November 19, 2009 Category: Cancer & Oncology Source Type: organizations
Health News of the DayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:Exercise remodels the brain, making it more stress-resistant (in rats, at least) http://bit.ly/QHkMUAnother study: Regular consumption of alcohol reduces the risk of heart disease by 30-50% http://bit.ly/FZQl3Young athletes should be screened for heart disease with 2 tests rather than 1: ECG and echocardiogram http://bit.ly/176Nuu55% of adult Americans don't want to get the H1N1 flu vaccine according to a poll http://bit.ly/...
Source: Clinical Cases and Images - November 19, 2009 Category: Journals (General) Tags: Health News of the Day Source Type: info
Altered Regulation of CD200 Receptor in Monocyte-Derived Macrophages from Individuals with Parkinson's Disease.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Microglia are the representative myeloid cells in the brain, and their over-activation plays an important role in the pathogenesis of Parkinson's disease (PD). Microglia activation is believed to be regulated by the CD200-CD200R signaling. As the peripheral counterpart of microglia, monocyte-derived macrophages (MDMs) share the same progenitor and antigen markers, and they have similar biological behaviors and mirror microglial function in the brain. Here, we studied CD200R expression and its regulation in MDMs from 32 PD cases, 27 age-matched old controls, and 28 young controls. We found that the basal CD200R expressi...
Source: Neurochemical Research - November 19, 2009 Category: Neuroscience Authors: Luo XG, Zhang JJ, Zhang CD, Liu R, Zheng L, Wang XJ, Chen SD, Ding JQ Tags: Neurochem Res Source Type: journals
World's First Delivery Of Intra-Arterial Avastin Directly Into Brain TumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2009 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news
World's First Delivery Of Intra-Arterial Avastin Directly Into Brain TumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 18, 2009 Category: Cancer & Oncology Tags: Neurology / Neuroscience Source Type: news
Pathologic complete response of a solitary melanoma brain metastasis after local ablative radiation therapy: case reportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abstract A 73-year-old female with malignant melanoma metastatic to her left frontal lobe status post-gross total resection of the
metastasis, whole brain radiotherapy, and Gamma Knife-based stereotactic radiosurgery for local recurrence presented with
an area of increasing enhancement on follow-up magnetic resonance imaging (MRI) and hypermetabolic lesions on 18-fluorodeoxyglucose
positron emission tomography/computerized tomography (18FDG PET/CT) of the brain suspicious for tumor recurrence. Surgical resection of the lesion was performed showing radiation
necrosis with no evidence of tumor. The patient was...
Source: Medical Oncology - November 18, 2009 Category: Cancer & Oncology Tags: Medical Oncology Source Type: journals
Patient Receives World's First Delivery Of Intra-arterial Avastin Directly Into A Malignant Brain TumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2009 Category: Consumer Health News Tags: cancer / Oncology Source Type: news
Patient Receives World's First Delivery Of Intra-arterial Avastin Directly Into A Malignant Brain TumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 18, 2009 Category: Cancer & Oncology Tags: cancer / Oncology Source Type: news
Suzanne Somers speaks out against the conventional cancer industry: mammograms, chemotherapy vs. alternative curesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(NaturalNews) As the author of the New York Times bestseller, "Knockout: Interviews with doctors who are curing cancer," Suzanne Somers is making waves across the cancer industry. Her powerful, inspired message of informed hope is reaching millions of readers who are learning about the many safe, effective options for treating cancer that exist outside the realm of the conventional cancer industry (chemotherapy, surgery and radiation).Recently, Suzanne Somers spoke with NaturalNews editor Mike Adams, the Health Ranger, to share the inspiration for her new book Knockout. "People are just starving for some new information......
Source: NaturalNews.com - November 18, 2009 Category: Consumer Health Advice Source Type: news
World's first delivery of intra-arterial Avastin directly into brain tumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Neurosurgeons have performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously or throughout their body. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 18, 2009 Category: Science Source Type: news
A multidimensional examination of correlates of fatigue during radiotherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The objective of the current study was to investigate cancer-related fatigue in a radiotherapy sample using a multidimensional conceptualization to determine whether correlates of fatigue are consistent across all dimensions or whether each fatigue dimension has its own unique pattern of correlates.The study used a prospective cohort design with data collected from radiotherapy patients at 3 time points; before, after, and 6 weeks after radiotherapy treatment.A total of 210 participants were enrolled in the study. Results indicated the following relations. Increased general fatigue was found to be associated with lower per...
Source: Cancer - November 18, 2009 Category: Cancer & Oncology Authors: Amanda Purcell, Jennifer Fleming, Sally Bennett, Kathleen McGuane, Bryan Burmeister, Terry Haines Source Type: journals
Hypermethylation and Transcriptional Downregulation of the TIMP3 Gene Is Associated with Allelic Loss on 22q12.3 and Malignancy in MeningiomasEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The gene for the tissue inhibitor of metalloproteinase 3 (TIMP3) on 22q12.3 had been reported to be inactivated by promoter methylation in various types of cancers, with controversial findings in meningiomas. We performed direct sodium bisulfite sequencing in a series of 50 meningiomas, including 27 benign meningiomas [World Health Organization (WHO) grade I], 11 atypical meningiomas (WHO grade II) and 12 anaplastic meningiomas (WHO grade III), and found hypermethylation of TIMP3 in 67% of anaplastic meningiomas, but only 22% of atypical and 17% of benign meningiomas. Moreover, TIMP3 methylation scores were significantly i...
Source: Brain Pathology - November 18, 2009 Category: Neurology Authors: Dimitri Barski, Marietta Wolter, Guido Reifenberger, Markus J. Riemenschneider Source Type: journals
Diagnosis of childhood cancer.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Childhood cancer is uncommon but remains the leading cause of disease-related death in children. Symptoms are often vague or insidious; they may suggest a more common alternative diagnosis, and they are quite different from those associated with adult malignancy. The skilled office practitioner must consider cancer as a diagnosis when symptoms/signs persist or when multiple symptoms point toward a possible diagnosis of malignancy. Early diagnosis is critical, as survival rates have increased dramatically over the past decades. Prolonged delay in diagnosis is common, especially for brain tumors and certain lymphomas (Ho...
Source: Primary Care - November 17, 2009 Category: Primary Care Authors: Raab CP, Gartner JC Tags: Prim Care Source Type: journals
World's first delivery of intra-arterial Avastin directly into brain tumorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously or throughout their body. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2009 Category: Global & Universal Source Type: news
Research On Brain Metastasis Detailed By Scientists At University Of PittsburghEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS). (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 17, 2009 Category: Cancer & Oncology Source Type: news
Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions and implications: Although the anthocyanidins under study may alter pharmacokinetics of drugs that are BCRP substrates, they are less likely to interfere with activities of MDR1 substrates. The present data suggest that several anthocyanins and anthocyanidins may be actively transported out of intestinal tissues and endothelia, limiting their bioavailability in plasma and brain. (Source: British Journal of Pharmacology)
Source: British Journal of Pharmacology - November 17, 2009 Category: Drugs & Pharmacology Authors: A Dreiseitel, B Oosterhuis, KV Vukman, P Schreier, A Oehme, S Locher, G Hajak, PG Sand Source Type: journals
Cross-Sectional Imaging Characteristics of Pituitary Adenomas, Invasive Adenomas and Adenocarcinomas in Dogs: 33 Cases (1988–2006)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pituitary tumors in dogs can be adenomas, invasive adenomas, or adenocarcinomas. In people, invasive adenomas and pituitary adenocarcinomas carry a worse prognosis than adenomas. To identify differentiating features on cross-sectional imaging in dogs with pituitary adenomas, invasive adenomas, and adenocarcinomas. Thirty-three dogs that had computed tomography (CT) or magnetic resonance imaging (MRI) performed and a necropsy diagnosis of pituitary adenoma (n= 20), invasive adenoma (n= 11), or adenocarcinoma (n= 2). Medical records were retrospectively reviewed for signalment, history, and diagnosis. CT and MR images were r...
Source: Journal of Veterinary Internal Medicine - November 17, 2009 Category: Veterinary Research Authors: Rachel E. Pollard, Christopher M. Reilly, Megan R. Uerling, Farica D. Wood, Edward C. Feldman Source Type: journals
Breaching a Barrier to Fight Brain CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An experimental treatment for glioblastoma suppresses a barrier to deliver a drug directly to brain tumors. (Source: NYT > Health)
Source: NYT > Health - November 16, 2009 Category: Consumer Health News Authors: By DENISE GRADY Tags: Avastin (Drug) tumors brain Medicine and Health Chemotherapy Source Type: news
Bevacizumab for recurrent ependymomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions: The radiographic response rate to bevacizumab-containing regimens is high. A prospective study is warranted. (Source: Neurology)
Source: Neurology - November 16, 2009 Category: Neurology Authors: Green, R. M., Cloughesy, T. F., Stupp, R., DeAngelis, L. M., Woyshner, E. A., Ney, D. E., Lassman, A. B. Tags: All Oncology, Primary brain tumor, Spinal cord tumor, Chemotherapy-tumor ARTICLES Source Type: journals
NIH funds brain imaging appEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prism Clinical Imaging and The Medical College of Wisconsin in Milwaukee are the recipients of a three-year grant from the National Institutes of Health (NIH) for the development and clinical validation of medical imaging software to aid in the diagnosis and treatment of brain cancer. (Source: Health Imaging News)
Source: Health Imaging News - November 16, 2009 Category: Radiology Tags: Latest News Source Type: news
Surviving After A Loved One's Suicide: Part IEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
There are two months out of the year I'm not too keen on living through. One is March, obviously, since that is the month in which my father committed suicide, a month that still, almost seven years later, smells the same, looks the same and all-around feels the same as that cold day in 2003. The other month is November; well, actually, it's more like a single day. November 21 is National Survivors of Suicide Day.<!--break--> Over the years, that's what I've learned to embrace - the fact that I am, indeed, a survivor. But, make no mistake. It took me six long years to get to this point, and this isn't really the endi...
Source: Psychology Today Relationships Center - November 16, 2009 Category: Psychiatry & Psychology Authors: Melissa Blake Tags: Health Parenting Psychiatry Relationships Self-Help afte bed sheets cold day committed suicide disability eerie silence family father few moments futility great man national survivors of suicide day rest of my life rest Source Type: consumer
Prism And Medical College Of Wisconsin Investigators Receive $1.6 Million NIH Grant To Develop Advanced Medical Imaging ToolsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH) to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 16, 2009 Category: Consumer Health News Tags: MRI / PET / Ultrasound Source Type: news
Prism And Medical College Of Wisconsin Investigators Receive $1.6 Million NIH Grant To Develop Advanced Medical Imaging ToolsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH) to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 16, 2009 Category: Cancer & Oncology Tags: MRI / PET / Ultrasound Source Type: news
Prometheus releases trio of tissue-specific microRNA testsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prometheus Laboratories has launched the ProOncDx line of cancer diagnostic tests. ProOncDx TumorSource pinpoints the tissue of origin in metastatic tumors in a number of cancers including breast, brain, kidney, colon, liver, ovary, lung, pancreas, and prostate. The test measures the expression level of 48 microRNA biomarkers. (Source: Cancer Network)
Source: Cancer Network - November 16, 2009 Category: Cancer & Oncology Source Type: info
Elm Grove firm, MCW win $1.6M fed grantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prism Clinical Imaging Inc. and investigators at the Medical College of Wisconsin have received a $1.6 million, three-year grant from the National Institutes of Health to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 16, 2009 Category: American Health Source Type: journals
Elm Grove firm, MCW win $1.6M fed grantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prism Clinical Imaging Inc. and investigators at the Medical College of Wisconsin have received a $1.6 million, three-year grant from the National Institutes of Health to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2009 Category: Biotechnology Source Type: journals
Image of brain tumour wins competitionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: BMJ Online First)
Source: BMJ Online First - November 16, 2009 Category: Journals (General) Authors: Christie, B. Tags: Neurooncology, CNS cancer NEWS Source Type: journals
Prism and Medical College of Wisconsin investigators receive $1.6 million NIH grant to develop advanced medical imaging toolsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Medical College of Wisconsin) Prism Clinical Imaging, Inc., in collaboration with investigators at the Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2009 Category: Global & Universal Source Type: news
Stem cells help brain heal after radiationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at the University of California have found a potential new use for human embryonic stem cells: helping cancer patients recover the cognitive function lost when their brains are treated with radiation.
People with tumors in their head or... (Source: OrlandoSentinel: Medical Research)
Source: OrlandoSentinel: Medical Research - November 16, 2009 Category: American Health Source Type: news
FAQ:Is an arachnoid cyst 4.25cm x 1.7 cm in the left middle cranial fossa with a mass effect on the temporal lobe concerning...Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - November 15, 2009 Category: Cancer & Oncology Source Type: clinical trials
This week on Thrive: Nov. 9 – 13Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Here’s a quick look at what Thrive was up to last week.
An eco-perspective is explored on H1N1. Survivors of childhood brain cancer face a variety of late effects and why you need to get rid of your old glass thermometers. Children’s explores how babies understand expressions and emotions and offers tips on how to prepare your child for a flu vaccine. A new study reveals that parents are out of touch about knowing their kids’ stress levels and a Children’s expert gives tip on how to help kids cope with the stress of having a parent at war. The HealthMap team gives us our weekly H1N1 update and your questions are an...
Source: Thrive, Children's Hospital Boston - November 15, 2009 Category: Pediatrics Authors: Children's Hospital Boston staff Tags: All posts Ask the Mediatrician asthma brain cancer Center on Media and Child Health Children's Hospital Informatics Program flu Flu vaccine food stamps glass thermometers h1n1 HealthMap injury Injury Prevention Michael Rich p Source Type: organizations
